Associate Professor Grahame Elder

Clinical Associate Professor
Medicine, Westmead Clinical School

Telephone +61 2 9845 6962
Fax +61 2 9868 5510

Map

Selected grants

2013

  • IMPROVE-CKD Study: Impact of a phosphate binder on cardiovascular disease in Chronic Kidney Disease; Hawley C, Elder G, Walker R, Block G, Faull R, Pedagogos E, Polkinghorne K, Toussaint N; National Health and Medical Research Council (NHMRC)/Project Grants.

Selected publications

Download citations: PDF RTF Endnote

Books

  • Harris, D., Elder, G., Kairaitis, L., Rangan, G. (2012). Pocket Guide to Clinical Dialysis. Sydney, Australia: McGraw-Hill Education.

Edited Books

  • Harris, D., Elder, G., Kairaitis, L., Rangan, G. (2005). Basic Clinical Dialysis. Sydney: McGraw-Hill, Medical Pub. Division.

Book Chapters

  • Elder, G. (2008). Bone and Mineral Metabolism. In David Harris (Eds.), Clinical Cases in Kidney Disease, (pp. 133-145). Australia: McGraw Hill.
  • Elder, G. (2008). Cardiovascular Mortality. In David Harris (Eds.), Clinical Cases in Kidney Disease, (pp. 124-132). Australia: McGraw Hill.

Journals

  • Toussaint, N., Pedagogos, E., Tan, S., Badve, S., Hawley, C., Perkovic, V., Elder, G. (2012). Phosphate in early chronic kidney disease: Associations with clinical outcomes and a target to reduce cardiovascular risk. Nephrology, 17(5), 433-444. [More Information]
  • Elder, G. (2011). Calcium supplementation: lessons from the general population for chronic kidney disease and back. Current Opinion In Nephrology And Hypertension, 20(4), 369-375. [More Information]
  • Bency, R., Roger, S., Elder, G. (2011). Hypercalcaemia as a prodromal feature of indolent Pneumocystis jivorecii after renal transplantation. Nephrology, Dialysis, Transplantation, 26(5), 1740-1742. [More Information]
  • Navaneethan, S., Palmer, S., Vecchio, M., Craig, J., Elder, G., Strippoli, G. (2011). Phosphate binders for preventing and treating bone disease in chronic kidney disease patients (Review). Cochrane Database of Systematic Reviews, 2011 (2), CD006023-1-CD006023-143. [More Information]
  • Palmer, S., Hayen, A., Macaskill, P., Pellegrini, F., Craig, J., Elder, G., Strippoli, G. (2011). Serum Levels of Phosphorus, Parathyroid Hormone, and Calcium and Risks of Death and Cardiovascular Disease in Individuals With Chronic Kidney Disease. JAMA: The Journal of the American Medical Association, 305(11), 1119-1127. [More Information]
  • Toussaint, N., Elder, G., Kerr, P. (2010). A rational guide to reducing fracture risk in dialysis patients. Seminars in Dialysis, 23(1), 43-54. [More Information]
  • Boudville, N., Inderjeeth, C., Elder, G., Glendenning, P. (2010). Association between 25-hydroxyvitamin D, somatic muscle weakness and falls risk in end-stage renal failure. Clinical Endocrinology, 73(3), 299-304. [More Information]
  • Mainra, R., Elder, G. (2010). Individualized Therapy to Prevent Bone Mineral Density Loss after Kidney and Kidney-Pancreas Transplantation. Clinical Journal of the American Society of Nephrology, 5(1), 117-124. [More Information]
  • Navaneethan, S., Palmer, S., Craig, J., Elder, G., Strippoli, G. (2009). Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials. American Journal of Kidney Diseases, 54(4), 619-637. [More Information]
  • Toussain, N., Elder, G., Kerr, P. (2009). Bisphosphonates in chronic kidney disease; balancing potential benefits and adverse effects on bone and soft tissue. Clinical Journal of the American Society of Nephrology, 4(1), 221-233. [More Information]
  • Mainra, R., Elder, G. (2009). Review article: Managing bone complications after kidney transplantation. Nephrology, 14(4), 437-442. [More Information]
  • O'Shaughnessy, D., Elder, G. (2009). Review article: Patient-level outcomes: the missing link. Nephrology, 14(4), 443-451. [More Information]
  • Palmer, S., McGregor, D., Craig, J., Elder, G., Macaskill, P., Strippoli, G. (2009). Vitamin D compounds for people with chronic kidney disease not requiring dialysis. Cochrane Database of Systematic Reviews, Article number CD008175(4), 1-47.
  • Palmer, S., McGregor, D., Craig, J., Elder, G., Macaskill, P., Strippoli, G. (2009). Vitamin D compounds for people with chronic kidney disease requiring dialysis. Cochrane Database of Systematic Reviews, Pages CD005633(4), 1-120.
  • Palmer, S., McGregor, D., Macaskill, P., Craig, J., Elder, G., Strippoli, G. (2007). Meta-analysis: vitamin D compounds in chronic kidney disease. Annals of Internal Medicine, 147(12), 840-853. [More Information]
  • Elder, G. (2007). Vitamin D levels, bone turnover and bone mineral density show seasonal variation in patients with chronic kidney disease stage 5. Nephrology, 12(1), 90-94. [More Information]
  • Elder, G., Mackun, K. (2006). 25-Hydroxyvitamin D deficiency and diabetes predict reduced BMD in patients with chronic kidney disease. Journal of Bone and Mineral Research, 21(11), 1778-84. [More Information]
  • Strippoli, G., Tong, A., Palmer, S., Elder, G., Craig, J. (2006). Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients. Cochrane Database of Systematic Reviews, 18(4), CD006254-CD006254. [More Information]
  • Elder, G. (2006). From marrow oedema to osteonecrosis: common paths in the development of post-transplant bone pain. Nephrology, 11(6), 560-567. [More Information]
  • Elder, G., Faull, R., Branley, P., Hawley, C. (2006). Management of bone disease, calcium, phosphate and parathyroid hormone. Nephrology, 11 Suppl 1, S230-S261. [More Information]
  • Strippoli, G., Palmer, S., Tong, A., Elder, G., Messa, P., Craig, J. (2006). Meta-Analysis of Biochemical and Patient-Level Effects of Calcimimetic Therapy. American Journal of Kidney Diseases, 47(5), 715-726. [More Information]
  • Strippoli, G., Palmer, S., Tong, A., Elder, G., Messa, P., Craig, J. (2006). Meta-analysis of biochemical and patient-level effects of calcimimetic therapy. American Journal of Kidney Diseases, 47(5), 715-726. [More Information]
  • Elder, G. (2005). Parathyroidectomy in the calcimimetic era. Nephrology, 10(5), 511-5. [More Information]
  • Elder, E., Elder, G., Larsson, C. (2005). Pheochromocytoma and functional paraganglioma syndrome: no longer the 10% tumor. Journal of Surgical Oncology, 89(3), 193-201. [More Information]

2012

  • Toussaint, N., Pedagogos, E., Tan, S., Badve, S., Hawley, C., Perkovic, V., Elder, G. (2012). Phosphate in early chronic kidney disease: Associations with clinical outcomes and a target to reduce cardiovascular risk. Nephrology, 17(5), 433-444. [More Information]
  • Harris, D., Elder, G., Kairaitis, L., Rangan, G. (2012). Pocket Guide to Clinical Dialysis. Sydney, Australia: McGraw-Hill Education.

2011

  • Elder, G. (2011). Calcium supplementation: lessons from the general population for chronic kidney disease and back. Current Opinion In Nephrology And Hypertension, 20(4), 369-375. [More Information]
  • Bency, R., Roger, S., Elder, G. (2011). Hypercalcaemia as a prodromal feature of indolent Pneumocystis jivorecii after renal transplantation. Nephrology, Dialysis, Transplantation, 26(5), 1740-1742. [More Information]
  • Navaneethan, S., Palmer, S., Vecchio, M., Craig, J., Elder, G., Strippoli, G. (2011). Phosphate binders for preventing and treating bone disease in chronic kidney disease patients (Review). Cochrane Database of Systematic Reviews, 2011 (2), CD006023-1-CD006023-143. [More Information]
  • Palmer, S., Hayen, A., Macaskill, P., Pellegrini, F., Craig, J., Elder, G., Strippoli, G. (2011). Serum Levels of Phosphorus, Parathyroid Hormone, and Calcium and Risks of Death and Cardiovascular Disease in Individuals With Chronic Kidney Disease. JAMA: The Journal of the American Medical Association, 305(11), 1119-1127. [More Information]

2010

  • Toussaint, N., Elder, G., Kerr, P. (2010). A rational guide to reducing fracture risk in dialysis patients. Seminars in Dialysis, 23(1), 43-54. [More Information]
  • Boudville, N., Inderjeeth, C., Elder, G., Glendenning, P. (2010). Association between 25-hydroxyvitamin D, somatic muscle weakness and falls risk in end-stage renal failure. Clinical Endocrinology, 73(3), 299-304. [More Information]
  • Mainra, R., Elder, G. (2010). Individualized Therapy to Prevent Bone Mineral Density Loss after Kidney and Kidney-Pancreas Transplantation. Clinical Journal of the American Society of Nephrology, 5(1), 117-124. [More Information]

2009

  • Navaneethan, S., Palmer, S., Craig, J., Elder, G., Strippoli, G. (2009). Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials. American Journal of Kidney Diseases, 54(4), 619-637. [More Information]
  • Toussain, N., Elder, G., Kerr, P. (2009). Bisphosphonates in chronic kidney disease; balancing potential benefits and adverse effects on bone and soft tissue. Clinical Journal of the American Society of Nephrology, 4(1), 221-233. [More Information]
  • Mainra, R., Elder, G. (2009). Review article: Managing bone complications after kidney transplantation. Nephrology, 14(4), 437-442. [More Information]
  • O'Shaughnessy, D., Elder, G. (2009). Review article: Patient-level outcomes: the missing link. Nephrology, 14(4), 443-451. [More Information]
  • Palmer, S., McGregor, D., Craig, J., Elder, G., Macaskill, P., Strippoli, G. (2009). Vitamin D compounds for people with chronic kidney disease not requiring dialysis. Cochrane Database of Systematic Reviews, Article number CD008175(4), 1-47.
  • Palmer, S., McGregor, D., Craig, J., Elder, G., Macaskill, P., Strippoli, G. (2009). Vitamin D compounds for people with chronic kidney disease requiring dialysis. Cochrane Database of Systematic Reviews, Pages CD005633(4), 1-120.

2008

  • Elder, G. (2008). Bone and Mineral Metabolism. In David Harris (Eds.), Clinical Cases in Kidney Disease, (pp. 133-145). Australia: McGraw Hill.
  • Elder, G. (2008). Cardiovascular Mortality. In David Harris (Eds.), Clinical Cases in Kidney Disease, (pp. 124-132). Australia: McGraw Hill.

2007

  • Palmer, S., McGregor, D., Macaskill, P., Craig, J., Elder, G., Strippoli, G. (2007). Meta-analysis: vitamin D compounds in chronic kidney disease. Annals of Internal Medicine, 147(12), 840-853. [More Information]
  • Elder, G. (2007). Vitamin D levels, bone turnover and bone mineral density show seasonal variation in patients with chronic kidney disease stage 5. Nephrology, 12(1), 90-94. [More Information]

2006

  • Elder, G., Mackun, K. (2006). 25-Hydroxyvitamin D deficiency and diabetes predict reduced BMD in patients with chronic kidney disease. Journal of Bone and Mineral Research, 21(11), 1778-84. [More Information]
  • Strippoli, G., Tong, A., Palmer, S., Elder, G., Craig, J. (2006). Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients. Cochrane Database of Systematic Reviews, 18(4), CD006254-CD006254. [More Information]
  • Elder, G. (2006). From marrow oedema to osteonecrosis: common paths in the development of post-transplant bone pain. Nephrology, 11(6), 560-567. [More Information]
  • Elder, G., Faull, R., Branley, P., Hawley, C. (2006). Management of bone disease, calcium, phosphate and parathyroid hormone. Nephrology, 11 Suppl 1, S230-S261. [More Information]
  • Strippoli, G., Palmer, S., Tong, A., Elder, G., Messa, P., Craig, J. (2006). Meta-Analysis of Biochemical and Patient-Level Effects of Calcimimetic Therapy. American Journal of Kidney Diseases, 47(5), 715-726. [More Information]
  • Strippoli, G., Palmer, S., Tong, A., Elder, G., Messa, P., Craig, J. (2006). Meta-analysis of biochemical and patient-level effects of calcimimetic therapy. American Journal of Kidney Diseases, 47(5), 715-726. [More Information]

2005

  • Harris, D., Elder, G., Kairaitis, L., Rangan, G. (2005). Basic Clinical Dialysis. Sydney: McGraw-Hill, Medical Pub. Division.
  • Elder, G. (2005). Parathyroidectomy in the calcimimetic era. Nephrology, 10(5), 511-5. [More Information]
  • Elder, E., Elder, G., Larsson, C. (2005). Pheochromocytoma and functional paraganglioma syndrome: no longer the 10% tumor. Journal of Surgical Oncology, 89(3), 193-201. [More Information]

To update your profile click here. For support on your academic profile contact .